CVS Health (NYSE:CVS) Shares Up 3.1% – Time to Buy?

CVS Health Corporation (NYSE:CVS)’s stock price rose 3.1% during trading on Wednesday. The stock traded as high as $88.82 and last traded at $89.1440. 919,503 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 8,265,509 shares. The stock had previously closed at $86.43.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS raised its outlook for the Health Care Benefits segment as stronger Medicare trends support expected margin recovery. Medical-cost pressures remain a concern, but the improved core trends are a significant catalyst for the stock. CVS’ Health Care Benefits Arm Shows Better Core Trends: What’s Ahead?
• Positive Sentiment: Commentary highlighted CVS as significantly undervalued, suggesting that much of the company’s negative news may already be reflected in its share price and leaving room for a recovery if operations improve. Why CVS Is ‘Insanely Cheap’
• Positive Sentiment: Analysts have a consensus price target of $107.24, well above the reported trading level, providing a bullish valuation signal if CVS executes against its earnings and margin-recovery plans. CVS Health Corporation Stock Has Consensus Price Target of $107.24
• Positive Sentiment: Analyst research points to CVS’s history of earnings surprises and favorable conditions for another beat in the upcoming report, supporting investor expectations for continued earnings momentum. Will CVS Health Beat Estimates Again?
• Neutral Sentiment: CVS opened its first pharmacy-focused location in the Boston area as part of a strategy to improve access to pharmacy care. The initiative may strengthen local service delivery, but its near-term financial impact is unclear. CVS Pharmacy Celebrates Opening of First Pharmacy-Focused Location
• Neutral Sentiment: CVS is promoting MMR vaccinations at more than 530 New York pharmacies and MinuteClinic locations amid a measles outbreak. The announcement reinforces CVS’s healthcare-access role but is unlikely to materially affect near-term earnings. CVS Health Reminds New Yorkers About MMR Vaccines
• Neutral Sentiment: CVS announced a $5 million scholarship donation to the University of Louisiana Monroe College of Pharmacy. The move supports workforce development and community relations but carries no immediate earnings benefit.
• Negative Sentiment: Medical-cost inflation remains the principal risk identified in coverage of the Health Care Benefits segment, potentially limiting the pace of margin improvement despite the raised outlook.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. HSBC reaffirmed a “hold” rating and set a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. Wells Fargo & Company raised their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Weiss Ratings raised shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. Finally, BMO Capital Markets set a $112.00 target price on CVS Health in a research note on Wednesday, September 9th. Twenty-two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $107.24.

CVS Health Trading Up 3.4%

The firm has a market cap of $114.25 billion, a price-to-earnings ratio of 23.62, a P/E/G ratio of 0.85 and a beta of 0.60. The business has a 50-day moving average of $93.81 and a 200-day moving average of $92.19. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period last year, the business posted $1.81 EPS. CVS Health’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be issued a $0.6650 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date is Thursday, October 22nd. CVS Health’s payout ratio is currently 70.37%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Elevation Wealth Partners LLC raised its stake in CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 105 shares during the period. Apella Capital LLC increased its holdings in shares of CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after buying an additional 117 shares during the last quarter. Wellington Altus USA Inc. raised its position in shares of CVS Health by 13.3% in the 2nd quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after buying an additional 120 shares during the period. CoreCap Advisors LLC grew its position in CVS Health by 4.2% during the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator’s stock valued at $360,000 after acquiring an additional 139 shares during the period. Finally, AGP Franklin LLC increased its stake in CVS Health by 1.3% during the first quarter. AGP Franklin LLC now owns 11,563 shares of the pharmacy operator’s stock worth $830,000 after acquiring an additional 146 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.